The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Novel Allogeneic Granulocyte-Macrophage Colony-Stimulating Factor–Secreting Tumor Vaccine for Pancreatic Cancer: A Phase I Trial of Safety and Immune Activation
Abstract
PURPOSE: Allogeneic granulocyte-macrophage colony-stimulating factor (GM-CSF)–secreting tumor vaccines can cure established tumors in the mouse, but their efficacy against human tumors is uncertain. We have developed a novel GM-CSF–secreting pancreatic tumor vaccine. To determine its safety and ability to induce antitumor immune responses, we conducted a phase I trial in patients with surgically resected adenocarcinoma of the pancreas. PATIENTS AND METHODS: Fourteen patients with stage 1, 2, or 3 pancreatic adenocarcinoma were enrolled. Eight weeks after pancreaticoduodenectomy, three patients received 1 × 10 7 vaccine cells, three patients received 5 × 10 7 vaccine cells, three patients received 10 × 10 7 vaccine cells, and five patients received 50 × 10 7 vaccine cells. Twelve of 14 patients then went on to receive a 6-month course of adjuvant radiation and chemotherapy. One month after completing adjuvant treatment, six patients still in remission received up to three additional monthly vaccinations with the same vaccine dose that they had received originally. RESULTS: No dose-limiting toxicities were encountered. Vaccination induced increased delayed-type hypersensitivity (DTH) responses to autologous tumor cells in three patients who had received ≥ 10 × 10 7 vaccine cells. These three patients also seemed to have had an increased disease-free survival time, remaining disease-free at least 25 months after diagnosis. CONCLUSION: Allogeneic GM-CSF–secreting tumor vaccines are safe in patients with pancreatic adenocarcinoma. This vaccine approach seems to induce dose-dependent systemic antitumor immunity as measured by increased postvaccination DTH responses against autologous tumors. Further clinical evaluation of this approach in patients with pancreatic cancer is warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Burris, H. A., Moore, M. J., Andersen, J., Green, M. R., Rothenberg, M. L., Modiano, M. R., Cripps, M. C., Portenoy, R. K., Storniolo, A. M., Tarassoff, P., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.6.2403 · Cited by 5,894
Dranoff, G., Jaffee, E., Lazenby, A., Golumbek, P., Levitsky, H., Brose, K., Jackson, V, Hamada, H., Pardoll, D., & Mulligan, R. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3539 · Cited by 2,818
Self-citationThe Central Role of CD4+ T Cells in the Antitumor Immune Response
Hung, K., Hayashi, R., Lafond-Walker, A., Lowenstein, C., Pardoll, D., & Levitsky, H. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2357 · Cited by 1,345
Self-citationRole of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor Antigens
Huang, A. Y. C., Golumbek, P., Ahmadzadeh, M., Jaffee, E., Pardoll, D., & Levitsky, H. (1994) · Science · doi:10.1126/science.7513904 · Cited by 1,160
Self-citationDesign and Analysis of Phase I Clinical Trials
Storer, B. E. (1989) · Biometrics · doi:10.2307/2531693 · Cited by 930
Human tumor antigens recognized by T lymphocytes.
Boon, T., & van der Bruggen, P. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.725 · Cited by 842
Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor
Wood, A. J. J., Lieschke, G. J., & Burgess, A. W. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207023270106 · Cited by 818
Boring, C. C., Squires, T. S., & Tong, T. (1991) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.41.1.19 · Cited by 617
Yeo, C. J., Abrams, R. A., Grochow, L. B., Sohn, T. A., Ord, S. E., Hruban, R. H., Zahurak, M. L., Dooley, W. C., Coleman, J., Sauter, P. K., et al. (1997) · Annals of Surgery · doi:10.1097/00000658-199705000-00018 · Cited by 595
Self-citationSoiffer, R., Lynch, T., Mihm, M., Jung, K., Rhuda, C., Schmollinger, J. C., Hodi, F. S., Liebster, L., Lam, P., Mentzer, S., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13141 · Cited by 571
Measurement of Delayed Skin-Test Responses
Sokal, J. E. (1975) · New England Journal of Medicine · doi:10.1056/nejm197509042931013 · Cited by 500
Simons, J. W., Mikhak, B., Chang, J.-F., DeMarzo, A. M., Carducci, M. A., Lim, M. K., Weber, C. E., Baccala, A. A., Goemann, M., Clift, S., et al. (1999) · PubMed · Cited by 463
Self-citationThe influence of surgical operations on components of the human immune system
Lennard, T. W. J., Shenton, B. K., Borzotta, A., Donnelly, P. K., White, M., Gerrie, L. M., Proud, G., & Taylor, R. M. R. (1985) · Journal of British Surgery · doi:10.1002/bjs.1800721002 · Cited by 406
Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor
Wood, A. J. J., Lieschke, G. J., & Burgess, A. W. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207093270207 · Cited by 371
Yeo, C. J., Cameron, J. L., Sohn, T. A., Coleman, J., Sauter, P. K., Hruban, R. H., Pitt, H. A., & Lillemoe, K. D. (1999) · Annals of Surgery · doi:10.1097/00000658-199905000-00003 · Cited by 359
Self-citationBrossart, P., Heinrich, K. S., Stuhler, G., Behnke, L., Reichardt, V. L., Stevanovic, S., Muhm, A., Rammensee, H.-G., Kanz, L., & Brugger, W. (1999) · Blood · doi:10.1182/blood.v93.12.4309 · Cited by 306
Berd, D., Maguire, H. C., McCue, P., & Mastrangelo, M. J. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.11.1858 · Cited by 300
Berd, D., Maguire, H. C., Jr., & Mastrangelo, M. J. (1986) · PubMed · Cited by 251
In Vivo Cross-Priming of MHC Class I–Restricted Antigens Requires the TAP Transporter
Huang, A. Y. C., Bruce, A. T., Pardoll, D. M., & Levitsky, H. I. (1996) · Immunity · doi:10.1016/s1074-7613(00)80248-4 · Cited by 224
Self-citationGreten, T. F., & Jaffee, E. M. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.3.1047 · Cited by 130
Self-citationJaffee, E. M., Schutte, M. E. M., Gossett, J., et al. (1998) · PubMed · Cited by 113
Self-citationDelayed cutaneous hypersensitivity reactions to membrane extracts of human tumour cells.
Oren, M. E., & Herberman, R. B. (1971) · PubMed Central · Cited by 108
McCune, C. S., O’Donnell, R., Marquis, D. M., et al. (1990) · Cancer Immunology Immunotherapy · doi:10.1007/bf01741726 · Cited by 103
Hoover, H. C., Surdyke, M. G., Dangel, R. B., et al. (1984) · PubMed · Cited by 96
Abrams, S. I., Khleif, S. N., Bergmann-Leitner, E. S., Kantor, J. A., Chung, Y., Hamilton, J. M., & Schlom, J. (1997) · Cellular Immunology · doi:10.1006/cimm.1997.1224 · Cited by 91
Protective antitumor immunity induced by immunization with completely allogeneic tumor cells.
Toes, R. E. M., Blom, R. J. J., van der Voort, E., Offringa, R., Melief, C. J. M., & Kast, W. M. (1996) · PubMed · Cited by 86
Identification of the Genes Encoding Cancer Antigens: Implications for Cancer Immunotherapy
Rosenberg, S. A., Kawakami, Y., Robbins, P. F., & Wang, R. (1996) · Advances in cancer research · doi:10.1016/s0065-230x(08)60874-x · Cited by 80
Cited by
Zhang, Y., & Zhang, Z. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0488-6 · Cited by 2,794
CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
Beatty, G. L., Chiorean, E. G., Fishman, M. P., Saboury, B., Teitelbaum, U. R., Sun, W., Huhn, R. D., Song, W., Li, D., Sharp, L. L., et al. (2011) · Science · doi:10.1126/science.1198443 · Cited by 1,672
Cytokines in cancer pathogenesis and cancer therapy
Dranoff, G. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1252 · Cited by 1,573
1423 Pancreaticoduodenectomies for Pancreatic Cancer: A Single-Institution Experience
Winter, J. M., Cameron, J. L., Campbell, K. A., Arnold, M. A., Chang, D. C., Coleman, J., Hodgin, M. B., Sauter, P. K., Hruban, R. H., Riall, T. S., et al. (2006) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2006.08.018 · Cited by 1,489
Self-citationThe Pancreas Cancer Microenvironment
Feig, C., Gopinathan, A., Neesse, A., Chan, D. S., Cook, N., & Tuveson, D. A. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3114 · Cited by 1,316
Metadata
- Authors
- Jaffee, E. M., Hruban, R. H., Biedrzycki, B., Laheru, D., Schepers, K., Sauter, P. R., Goemann, M., Coleman, J., Grochow, L., Donehower, R. C., Lillemoe, K. D., O’Reilly, S., Abrams, R. A., Pardoll, D. M., Cameron, J. L., & Yeo, C. J.
- Venue
- Journal of Clinical Oncology
- Published
- 2001-01-01
- Volume
- 19
- Issue
- 1
- Pages
- 145-156
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2124757685
- Cited by
- 600
- References
- 27
- FWCI
- 11.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.